期刊文献+

1例精神分裂症患者的用药分析与药学监护 被引量:5

Drug Analysis and Pharmaceutical Care for Patients with Schizophrenia
暂未订购
导出
摘要 目的探讨临床药师在精神分裂症患者治疗过程中的作用。方法临床药师参与治疗全过程,与临床医师共同制定最佳的治疗方案。结果临床药师通过全程药学监护,降低了不良反应发生率。结论临床药师和临床医师共同合作,促进临床合理用药。 Objective To explore the role of clinical pharmacists in patients with schizophrenia treatment process. Methods Clinical pharmacists to participate in the whole treatment process, and clinical doctors to work out the best treatment plan. Results Clinical pharmacists through the entire pharmaceutical care, reduce the incidence of adverse reactions. Conclusion Clinical pharmacists and clinical doctors work together, to promote clinical rational drug use.
出处 《中国医药指南》 2014年第7期226-226,共1页 Guide of China Medicine
关键词 药学监护 精神分裂症 临床药学 临床药师 Pharmaceutical care Schizophrenia Clinical Pharmacy Clinical pharmacists
  • 相关文献

参考文献6

  • 1李蒙燕,潘小平,林材元,王思荣,刘月香,余健敏,郑浩.抗精神病药物引起的恶性综合征1例及文献复习[J].临床荟萃,2006,21(9):663-664. 被引量:6
  • 2Chandran GJ,Mikler JR,Keeqan DL.Neuroleptic malignantsyn- drome :case report and discussion[J].CMAJ,2003,169(5):439-442.
  • 3Waldorf S.AANA journal co .urse.Update for nurse anesthetists. Neuroleptic malignant syndrome[J].AANA J,2003,71 (5):389-394.
  • 4王红星,白培深.对恶性综合征再认识[J].国外医学(精神病学分册),2004,31(3):160-163. 被引量:20
  • 5Bendolfi G,Dufour H,Patris M,et al.Risperidone versus clozapine in tream Iment- resistant chronic schizophrenia: a random izeddouble- blind study[J].AM Psychiatry, 1998,155(4):499-502.
  • 6Kelly DL,Conleyr R,Feldman S,et al.Ad junetdivalproex or Lithi- um to clozapine in treatment- resistant schizophrenia[J].Psychiatry, 2006,77(1) :81-95.

二级参考文献23

  • 1栾亦木.恶性综合征[J].日本医学介绍,1995,16(2):73-76. 被引量:3
  • 2Kawanishi C:Am J Pharmacogenomics,2003;3:89—95.
  • 3Bottlender R,et al:Pharmacopsychiatry,2002;35:119—121.
  • 4Schatzberg AF,Nemeroff CB:The American Psychiatric Press:textbook of psychopharmacology.2nded.318—925,American Psychiatric Press,1 998.
  • 5American Psychiatric Association:DSM-Ⅳ,international version with ICD-10 codes.757—760,American Psychiatric Press,1 995.
  • 6Peiris DTS,et al:J Neurol Neurosurg Psychiatry,2000;69:277—278.
  • 7Hall KL,et al:Psychopharmacol Bull.2001;35:49—54.
  • 8Berardi D,et al:Hum Psychopharmacol.2002;17:99—102.
  • 9Kaplan HI,Sadock BJ:Comprehensive textbook of psychiatry/Ⅵ.6 1 2—2005,Williams & Wilkins,1 995.
  • 10Hermesh H,et al:J Clin Psychopharmacol.2002;22:252—256.

共引文献23

同被引文献39

  • 1王红英,刘兵东.氯氮平中毒1例抢救成功报告[J].中国中西医结合急救杂志,2010,17(1):45-45. 被引量:3
  • 2中华医学会精神科分会.中国精神障碍分类与诊断标准[M].3版.济南:山东科学技术出版社,2001:108-1150.
  • 3Padmanabhan JL, Tandon N, Hailer CS, et al. Correlations Be- tween Brain Structure and Symptom Dimensions of Psychosis in Schizophrenia, Schizoaffective, and Psychotic Bipolar I Disorders [J]. Schizophr Bull. 2014 Jun 6. pii: sbu075.
  • 4Kerkemeyer L, Mostardt S, Biermann J, et al. Evaluation of an in- tegrated care program for schizophrenia: concept and study design [J]. Eur Arch Psychiatry Clin Neurosci. 2014. PMID: 24906973.
  • 5郭中孟,胡斌,龚发金,刘哲宁.精神分裂症的预后和结局研究进展[J].临床精神医学杂志,2007,17(6):421-422. 被引量:15
  • 6Lesem MD, Zajecka JM, Swift RH, et al. Intramuscular ziprasidone, 2 mg versus 10 mg, in the short- term management of agitated psychot- ic patients[ J]. J Clin Psychiatry ,2001,62 ( 1 ) : 12 - 18.
  • 7?,arnahan RM, Lund BC, Perry PJ. Ziprasidone, a new atypical antip- ~ychotic drug[ J]. Pharmacotberapy,2001,21 (6) :717 - 730.
  • 8Caley CF, Cooper CK. Ziprasidone: the fifth atypical antipsychotic [ J ]. Ann Pharmacother,2002,36 ( 5 ) : 839 - 851.
  • 9申文武,邓红,邱昌建,张树森,张倬秋,陶庆兰,沈峰,耿婷,朱燕,吴嘉,孙学礼.系统健康教育对恢复期精神分裂症患者康复效果的研究[J].护理管理杂志,2009,9(12):43-45. 被引量:6
  • 10王旸,曹昱,张艳.帕利哌酮缓释片对精神分裂症疗效及安全性的对照研究[J].精神医学杂志,2009,22(6):415-419. 被引量:91

引证文献5

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部